Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Schistosomiasis Treatment and HIV Susceptibility
NCT02878564Phase 4Completed
- Sponsor
- University of Toronto
- Start
- Mar 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of praziquantel in schistosomiasis mansoni, sponsored by University of Toronto. Started Mar 2016; status: completed.
02
Drugs
praziquantel
03
Conditions
schistosomiasis mansoni
Beyond the preview
Go deeper on NCT02878564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02878564.